Consider raising AstraZeneca vax age threshold, says top haematologist
The severity of clot cases should prompt a rethink for people in their 50s, he says
Australia needs to “look closely” at whether the threshold age for receiving the AstraZeneca COVID-19 vaccine should be raised to 60 in the wake of severe cases of thrombosis with thrombocytopenia syndrome, a leading expert on the rare disorder says.
The Australian Technical Advisory Group on Immunisation’s (ATAGI) advice is that the Pfizer vaccine is preferred for people under 50 because of a higher incidence of thrombosis with thrombocytopenia syndrome (TTS).
